Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May;14(5):1116-1123.
doi: 10.14202/vetworld.2021.1116-1123. Epub 2021 May 8.

Potential antimicrobial properties of the Ulva lactuca extract against methicillin-resistant Staphylococcus aureus-infected wounds: A review

Nadya Fianny Ardita  1 , Lenny Mithasari  1 , Daris Untoro  1 , Siti Isrina Oktavia Salasia  2
Affiliations
Review

Potential antimicrobial properties of the Ulva lactuca extract against methicillin-resistant Staphylococcus aureus-infected wounds: A review

Nadya Fianny Ardita et al. Vet World. 2021 May.

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA), currently a major problem in hospitals worldwide, is one of the most common causes of nosocomial disease through surgical wound infection. MRSA-infected wounds have very low recovery rates and have become more problematic as some antibiotics are not effective against MRSA. Several antimicrobial and anti-inflammatory agents of green algae (Ulva lactuca) in the form of alkaloids, triterpenoids, steroids, saponins, and flavonoids have the potential to accelerate the wound healing process following MRSA wound infection. Various active compounds contained in the U. lactuca extract are thought to have multiple antibacterial and anti-inflammatory properties that can overcome the MRSA antimicrobial resistance and accelerate tissue growth in the wound healing process. This review aims to describe the potential of Ulva lactuca extract against MRSA-infected wound healing.

Keywords: Ulva lactuca; antibacterial; methicillin-resistant Staphylococcus aureus; wound infection.

PubMed Disclaimer

References

    1. Khan H.A, Baig F.K, Mehboob R. Nosocomial infections:Epidemiology, prevention, control and surveillance. Asian Pac. J. Trop. Biomed. 2017;7(5):478–482.
    1. Curcio D, Francisco A.C, Correa F.J. Surgical site infection in elective clean and clean-contaminated surgeries in developing countries. Int. J. Infect. Dis. 2018;80(5):34–45. - PubMed
    1. Poorabbas B, Mardaneh J, Rezaei Z, Kalani M, Pouladfar G, Alami M.H, Soltani J, Shamsi-Zadeh A, Abdoli-Oskooi S, Saffar M.J, Alborzi1 A. Nosocomial infections:Multicenter surveillance of antimicrobial resistance profile of Staphylococcus aureus and Gram-negative rods isolated from blood and other sterile body fluids in Iran. Iran J. Microbiol. 2015;7(3):127–135. - PMC - PubMed
    1. World Health Organization. Antimicrobial Resistance. Geneva: World Health Organization; 2020. [Retrieved on 01-09-2020]. Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance .
    1. Mawalla B, Mshana S.E, Chalya P.L, Imirzalioglu C, Mahalu W. Predictors of surgical site infections among patients undergoing major surgery at Bugando medical centre in Northwestern Tanzania. BMC Surg. 2011;11(21):1–7. - PMC - PubMed

LinkOut - more resources